Hsbc Holdings PLC Cabaletta Bio, Inc. Transaction History

Hsbc Holdings PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.99 - $2.11 $1,817 - $3,873	-1,836 Reduced 12.19%	13,227 $14,000
Q1 2022 May 16, 2022	SELL	$1.68 - $3.92 $14,318 - $33,410	-8,523 Reduced 36.14%	15,063 $31,000
Q4 2021 Feb 11, 2022	SELL	$3.36 - $14.64 $11,612 - $50,595	-3,456 Reduced 12.78%	23,586 $89,000
Q3 2021 Nov 12, 2021	SELL	$7.0 - $12.5 $97,265 - $173,687	-13,895 Reduced 33.94%	27,042 $334,000
Q2 2021 Aug 13, 2021	BUY	$7.2 - $11.73 $18,604 - $30,310	2,584 Added 6.74%	40,937 $352,000
Q1 2021 May 14, 2021	BUY	$10.39 - $14.53 $146,447 - $204,800	14,095 Added 58.1%	38,353 $425,000
Q4 2020 Feb 12, 2021	SELL	$9.81 - $15.8 $33,972 - $54,715	-3,463 Reduced 12.49%	24,258 $302,000
Q3 2020 Nov 12, 2020	BUY	$9.71 - $14.41 $97,459 - $144,633	10,037 Added 56.76%	27,721 $305,000
Q2 2020 Aug 14, 2020	BUY	$6.39 - $11.28 $113,000 - $199,475	17,684 New	17,684 $197,000

126

47.9M

202K

110K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $76M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.